Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Concordia International Corp (CXR.TO)

Concordia International Corp (CXR.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Concordia International Corp 277 Lakeshore Road East Suite 302 Oakville ON L6J 1H9 CAN

P: 905-842-5150

Description:

Concordia International is a biotechnology company that manages, acquires, and develops drugs. The company's operations include pharmaceutical products and orphan drugs. The product portfolio includes legacy drugs that have reached full maturity but continue to generate predictable revenue. Concordia focuses on products with a well-established record of safety and efficacy, as well as a history of stable, predictable prescription demand regardless of the stage of the product's life cycle.

Key Statistics

Overview:

Market Capitalization, $K 1,222,837
Shares Outstanding, K 48,913
Annual Sales, $ 0 K
Annual Net Income, $ 0 K
60-Month Beta -2.20
% of Institutional Shareholders 14.97%

Growth:

1-Year Return -88.08%
3-Year Return -99.83%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date 11/13/18
Earnings Per Share ttm -2,158.62
Annual Dividend Rate, $ 0.00
Most Recent Dividend 22.502 on 07/13/16
Next Ex-Dividends Date 07/13/16
Dividend Payable Date 07/29/16
Dividend Payout Ratio 0.00%
Most Recent Split 300-1 on 09/11/18

CXR.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 9.12
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % 48.60%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 3.07
Book Value/Share N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar